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INTRODUCTION
Liposuction is a cosmetic surgery to remove the 
excess fat in the panniculus adipose found in both 
men and women by using a cannula with the assis-
tance of a powerful vacuum.1,2 In the US itself, more 
than 341.000 liposuctions were performed just in 
2008 and it was ranked second among all invasive 
cosmetic procedures, according to the American 
Society for Aesthetic Plastic Surgery.1,3 
One of the most important aspects of the 
successfulness of this procedure is the physical 
condition of the patient at the time of surgery.3 
The patient should be well optimized and must be 
assessed by the same standards as anyone else who 
is undergoing any surgery, including a complete 
preoperative history and physical examination. 
Preoperative evaluation reveals that the patients 
undergoing major liposuction procedure have a 
greater associated comorbid condition with the 
incidence of obesity. 
In general, obese patients should not be consid-
ered for ambulatory liposuction procedure and 
the general anesthesia with controlled mechanical 
ventilation is recommended. The goals of general 
anesthesia are a smooth induction, a prompt recov-
ery, and minimal side effects postoperatively, such 
as nausea, vomiting, or a sore throat.5 
However, all these goals of general anesthesia 
in an obese patient are not without any challenges, 
especially associated with the abnormal upper 
airway anatomical features: fat face and cheeks, 
short and a very thick neck, and a Mallampati score 
of 3 or higher are the reliable likelihood of a difficult 
intubation.2 Moreover, the induction and ventila-
tion of an obese patient is not without a risk too, 
as they may have a decreased functional residual 
capacity (FRC), decreased lung oxygen reserves, 
and suffering earlier desaturation during periods 
of hypoventilation or apnea than do normal-weight 
patient.2 
Intraoperative fluid management in liposuction 
procedure is also different from other surgeries 
where the total fluids received by the patient is 
intravenous fluids given by Anesthesiologist and 
volume of wetting solution injected by the surgeon. 
Meanwhile, the output includes the urine output 
and saline portion from the wetting solution, 
fat, and blood in the lipoaspirate.1,4 The residual 
volume is the difference between them, which 
remains in the extravascular compartment and 
acts as an interstitial infusion, thus any excess of 
fluid administered can easily produce fluid over-
load, which is an important cause of morbidity in 
these obese patients, hence the accurate intake and 
output monitoring utilized must be made.3 
Eventually, postoperative care and monitoring 
include pain relief management and prevention 
of potential major complication, such as deep 
vein thrombosis (DVT), pulmonary embolism, fat 
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ABSTRACT
Liposuction or lipoplasty is one of the most popular treatment modalities 
in aesthetic surgery which brings the certain unique anesthesia 
considerations. The patient should be assessed by the same standards 
as anyone else who is undergoing any surgery including a complete 
preoperative history and physical examination. The patients undergoing 
major liposuction procedure have a greater associated comorbid 
condition with the incidence of obesity. Moreover, intraoperative 
fluid management in liposuction procedure is also different from 
other surgeries where this procedure has the higher risk for fluid 
overload. Some complications related to liposuction are pulmonary 
thromboembolism, fat embolism syndrome, and anesthesia-related 
complications. This case report describes an obese class I (BMI >30.3 
kg/m2) patient who was undergoing an elective tumescent liposuction 
surgery under general anesthesia. During surgery, this patient received 
total subcutaneous infiltration of 1,200 mL tumescent solution and the 
total lipoaspirate was 3,300 mL. The surgery was uneventful without 
any certain complication. The anesthetic management of liposuction 
includes the preoperative evaluation, with particular attention to 
anything that might predispose the patient to complications, being 
essential to avoid unwanted occurrences. 
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embolism syndrome (FES), and anesthesia-related 
complications should be judicious addressed.4
CASE REPORT
A 48-years-old Caucasian male, 108 kg, 188 cm, 
ASA II, was admitted and planned for liposuction 
procedure with tumescent solution infiltration 
technique to remove excess fat in the abdominal 
area under general anesthesia. His past medical 
story included mild intermittent asthma with 
occasional salbutamol inhaler usage which his last 
attack was several years ago. 
He underwent an orthopedic surgery before due 
to a closed fracture of right radial bone by general 
anesthesia without any complications. He was not 
an active smoker, other than his obese body mass 
index (BMI) classification, no present systemic 
medical history was recorded. His physical exam-
ination upon admission was normal, and his preop-
erative vital signs were unremarkable. 
His BMI was defined as obesity class I with 
BMI was 30.32 kg/m2 and waist circumference was 
110 cm (43.30 inches). The physical examinations 
upon chest region were negative for additional 
abnormal breathing sounds such as expiratory 
wheezing or any sign of increasing the work of 
breathing, and his heart sounds were unremarkable. 
LEMON assessment for difficult intubation found 
as follow: unremarkable external look, adequate 
alignment of the oral, pharyngeal, and laryngeal 
axes by 3-3-2 evaluation, Mallampati class II, no 
obvious obstruction of the airway, and his neck 
mobility was normal. 
The preoperative laboratory testing and imaging 
workups included 12 leads of electrocardiogram 
(ECG) and chest X-ray posteroanterior view was 
unremarkable. By the hospital standard, he was on 
DVT prophylaxis with wearing compression stock-
ings, applied since admission. 
Upon arrival at the operating theatre, the 
patient was on supine position and monitored by 
noninvasive blood pressure (NIBP), electrocardio-
gram (ECG), and pulse oximetry (SpO2) were set 
on every 5 minutes-interval recorded. A blanket 
warmer was applied on to prevent hypothermia. 
He received premedication with midazolam 2 mg 
(0.01mg/kg BW) at the preparation room and 
co-induction with fentanyl 100mcg (1mcg/kg BW) 
intravenously. 
Anesthesia was initiated with induction of 
propofol 200 mg IV (2 mg/kg BW), then tracheal 
intubation was facilitated by rocuronium 50 mg 
IV (0.5mg/kg BW). First attempt intubation was 
executed by placing a ramp-shaped pillow behind 
his head, putting him in the sniffing position, but it 
was unsuccessful due to lack of glottic visualization. 
The patient was pre-oxygenated again and the 
second attempt of direct intubation was done by 
removing the pillow and switching the size of 
laryngoscope’s blade into a 4.0 Macintosh blade. 
We successfully intubated the patient with a 7.5 
Fr  endotracheal tube, confirmed with bilateral, 
equal breath sounds. 
Initial end-tidal CO2 (EtCO2) was 34-36 mmHg. 
The endotracheal tube was fixed and a pharyngeal 
packing was placed on. The ETT was connected 
to the mechanical ventilator on volume control 
mode-on, set to tidal volume (TV) 500 ml, respira-
tion rate (RR) 12x/min, I:E ratio of 1:2, peak pres-
sure of 17 mmHg, and FiO2 at 40%. The patient was 
maintained under anesthesia by N2O:O2=60%:40% 
and sevoflurane with targeted minimal alveolar 
concentration (MAC) to 1.0-1.2. 
Tumescent liposuction was performed and a 
total subcutaneous infiltration of 1,200 ml normal 
saline solution mixed with epinephrine 1mg was 
infiltrated. During surgery, he received esomepra-
zole 40 mg, metoclopramide 10 mg, and ketorolac 
30 mg intravenously. Through the length of surgery, 
the patient was on the controlled hemodynamic 
status with MAP ranged within 65-72mmHg, heart 
rate within 70-80 beat per minutes, SpO2 at 98%, 
temperature at 36.0°C, and EtCO2 at 32-36mmHg. 
The surgery was uneventful and lasted for about 
2  hours and 52 minutes. He received tramadol 
50  mg intravenously just before surgery ended 
for postoperative analgesia. At the end of surgery, 
sevoflurane was stopped, salivary secretion gently 
cleansed and suctioned, oropharyngeal airway 
device (OPA) 120 mm was inserted, then the patient 
was extubated. Muscle relaxation was reversed with 
neostigmine 1 mg (0.01 mg/kg BW) and atropine 
sulfate 0.5 mg (0.005 mg/kg BW) intravenously. 
The total intravenously fluid administration 
was 900 ml of Ringer’s lactate and total lipoaspi-
rate 3.300 ml consisted of infiltration solution, fat, 
and blood. The estimated blood loss was 50 ml. 
He was then observed at the post-anesthesia care 
unit (PACU). He reported postoperative pain with 
scale 6 and received paracetamol 1g intravenously. 
His Aldrette’s score was 9-10-10 during the first 
30 minutes and he was discharged to the ward 
within 2 hours after anesthesia without significant 
complaints. 
He was admitted for 2 days inward, still on 
compression stockings. There was one episode 
of postoperative nausea and vomiting (PONV) 
reported, however, it was relieved by the adminis-
tration of ondansetron 8 mg IV. Meanwhile, post-
operative pain was well controlled using ketorolac 
30 mg IV in combination with oral paracetamol 
500 mg and codeine 30 mg administered 8 hourly. 
On the second day after surgery, he has had a good 
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ambulation, wore an abdominal compression 
garment, a tolerable pain scale and no more nausea/
vomiting without anti-emetic medication, thus the 
patient can be discharged from the hospital.
DISCUSSION
Based on the volume of infiltration or wetting solu-
tion injected, liposuction techniques are divided 
into four main types: viz dry, wet, super wet, and 
tumescent technique. The tumescent technique is 
the most common of all liposuction procedure. It 
uses large volume (2-3 ml of infiltrating per 1ml of 
aspirate) of a mixture of lidocaine (the dosage used 
can be up to 35 mg/kg BW), adrenaline, and normal 
saline which are injected into the subcutaneous fat 
tissue to expand it and make it firm and turgid, 
before fat can be removed.1,3,4 
The tumescent liposuction technique in this case 
report used the modified infiltration solution by 
using normal saline infiltration only with the small 
dosage of epinephrine without lidocaine. Some 
data on anesthesia studies have revealed the use of 
lidocaine and epinephrine may result in toxicity 
in some cases, especially for the central nervous 
system and cardiac arrhythmia.3 Throughout intra-
operative monitoring, ECG showed unremarkable 
sinus rhythm without any premature extra beat or 
cardiac arrhythmia episode.
Preoperative evaluation is the crucial compo-
nent in establishing patient’s level of risk, since 
many obese patients undergoing liposuction may 
have other comorbidities condition like hyperten-
sion, diabetes mellitus type 2 (DMT2), obstructive 
sleep apnea (OSA), asthma or other pulmonary 
diseases, and coronary artery disease (CAD). 
Special attention should be addressed to look 
for the possibility of upper airway abnormality 
that may predispose the likelihood of a difficult 
intubation and mechanical ventilation in obese 
patients. The mnemonic LEMON is helpful as a 
prompt method when assessing the potential for a 
difficult intubation. It consists of some points: look 
externally of the anatomic features and character-
istic of the upper airway: fat face and cheeks, short 
and increased neck circumference at the level of 
thyroid cartilage; evaluate 3-3-2 rule to allow align-
ment of the oral, pharyngeal, and laryngeal axes; 
Mallampati classification for hypopharynx visual-
ization; obstruction of the airway (if any); and neck 
mobility.2,6 
LEMON assessment of this patient was unre-
markable. Patient’s past medical history of mild 
intermittent asthma and BMI at 30.32 kg/m2 may 
influence his pulmonary function in the perioper-
ative period, thus classifying him as ASA class II. 
The obese population are associated with decreased 
lung compliance, decreased of FRC, and increased 
airway resistance. These changes are most evident 
in the supine position, thus making controlled 
mechanical ventilation problematic. 
Currently, there are no data to indicate which 
mode of mechanical ventilation is best for obese 
patients. In the acute asthmatic attack with 
concomitant pulmonary infection or significant 
dyspnea notified, the patient should be referred 
to a pulmonologist, further medical stabilization, 
and general endotracheal intubation postponing 
for up to 5  weeks until the patient is completely 
asymptomatic. However, with regard to treated 
stable pulmonary disease, it probably confers no 
additional risk for perioperative complications. 
There is no definitive evidence or prospective and 
randomized studies to indicate which medication 
or anesthesia technique would be more superior or 
improve patient outcome.5 
In this patient, we need to do twice attempts of 
direct intubation after manual adjusted his neck 
to “the sniffing position” without a ramp-shaped 
pillow behind his head and switched the size of 
laryngoscope’s blade into a 4.0 Macintosh blade, 
then ETT was successfully connected to a ventila-
tor with volume controlled mode on. Intraoperative 
monitoring showed no hypoventilation and hypox-
emia episode occurred.
Patients with clinically obese are increased risk 
of pulmonary aspiration due to higher incidence 
of a hiatal hernia, reduced gastric motility, gastro-
esophageal reflux disease (GERD), and increased 
gastric volume (>25ml with pH<2.5 in >75% 
obese patient), thus abstinence from solid food 
ingestion for 10-12 hours prior surgery is recom-
mended. These patients may benefit from selected 
prophylactic treatments with H2 receptor antag-
onist (ranitidine 100 mg IV 60-90 minutes before 
surgery) which can reduce gastric volume and pH 
effectively. Alternatively, a proton pump inhibitor 
may prove to be a safe and effective alternative to 
the H2 receptor antagonist. A gastrokinetic agent 
(metoclopramide 10-20 mg IV) which increase 
gastric motility and lower esophageal sphincter 
tone, may be effective to for certain patient.5,8 This 
patient has conducted preoperative fasting for more 
than 8 hours and received esomeprazole 40 mg in 
combination with metoclopramide 10 mg intrave-
nously during surgery. 
General anesthesia is especially appropriate 
when surgery involves a large volume of liposuc-
tion, especially in the thigh, abdomen, and buttocks 
area.4 For induction, the special consideration 
needs to be addressed for a patient with decreased 
mandibular and neck mobility due to excessive fat 
tissue by planning for awake intubation with fiber 
optic laryngoscope and anticipation for the faster 
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desaturation period during periods of hypoventila-
tion should be considered.2,8 
Balanced general anesthesia technique is used 
for maintenance, which employed a combination 
of medications from different classes of rapid 
onset and shorter duration of anesthetic agents 
to achieve the desired level of sedation and anal-
gesic effect, thus reducing the morbidity in the 
obese patient. Typically, sedative/tranquilizer 
such as benzodiazepine (midazolam 1-2 mg IV) is 
combined with a narcotic analgesic such as fentanyl 
(1-10 mcg/kg BW/hr IV), morphine, or meperi-
dine. Other medications with the sedative-hypnotic 
effect such as propofol (1.5-2.5mg/kg BW IV for 
induction and 50-200mcg/kg/min IV for main-
tenance) may be administered. Fentanyl has the 
advantage of rapid onset and short duration which 
less than 60 minutes of action, however, because the 
synergistic action with other sedative agents, even 
doses 25-50 mcg can result in depression or respira-
tory. Adjunct analgesic with ketorolac can be added 
for analgesic activity. 
As long as the obese patient is carefully moni-
tored, several medications may be titrated together 
to achieve the required effects. A fixed combination 
of medications are not advised.5,8 Standards ASA 
monitoring such as noninvasive blood pressure 
(NIBP), EtCO2, ECG, and temperature monitoring 
should be done and noted every 5 minutes in the 
anesthesia recorded. Invasive monitoring such as 
central venous pressure (CVP) line and arterial 
blood pressure are required for a morbidly obese 
patient (BMI ≥35kg/m2) and undergoing large 
volume of liposuction (≥4.000 ml volume aspira-
tion carried out).4 
The intraoperative fluid administration in the 
liposuction procedure is different from other 
surgeries where the total fluids received by the 
patient is a summation of intravenous fluids given 
by anesthesiologist and volume of wetting solution 
injected by the surgeon, meanwhile, the output 
includes the urine output and saline portion from 
wetting solution, fat, and blood in the lipoaspirate.1,4 
The residual volume is the difference between them, 
which remains in the extravascular compartment 
and acts as an interstitial infusion, thus any excess 
fluid administered can easily produce fluid over-
load (hypervolemic). To limit the degree of fluid 
overloading and possibility of pulmonary edema, 
Rohrich et al. suggested guidelines for intraopera-
tive fluid resuscitation. 
The patient will receive maintenance fluid only 
plus subcutaneous infiltrate if they are having 
<5,000 ml of lipoaspirate, whereas those having 
>5,000 ml of lipoaspirate removal, received main-
tenance plus 0.25 ml of intravenous fluid for each 
milliliter aspirated over 5,000 ml plus subcutaneous 
infiltrate. This patient has received 2,100 ml total 
volume IV with tumescent solution infiltrated and 
3,300 ml of total volume aspirate, hence patient 
should receive maintenance fluid only plus subcuta-
neous infiltrate. Based on the 4-2-1 rule calculation 
he should be given 440 ml intravenously of mainte-
nance fluid for 3 hours of surgery. The sum of total 
intraoperative fluid should be 1.640ml, hence this 
patient has been slightly overhydrated however he 
did not develop any sign of fluid overload. 
Special attention should be addressed for intra-
operative positioning in liposuction surgery. The 
purpose is how to provide adequate surgical expo-
sure according to plastic surgeon request and area 
need to be fat aspirated, while maintaining adequate 
ventilation and prevent desaturation and hypoven-
tilation. Some morbidly obese patient needs to use 
a ramp-shaped pillow that extends from behind the 
lumbar area to the neck and adjusted head posi-
tion above the chest in a horizontal plane formed 
between sternal notch and the external auditory 
meatus. This position has benefits to facilitate intu-
bation and better ventilator mechanics. In addition, 
particular care should be employed in protecting 
pressure area prone of pressure sore and nerve inju-
ries (i.e. brachial plexus, sciatica, and ulnar nerves 
palsies), which are more common in a morbidly 
obese patient. Appropriate precaution should be 
taken by carefully padding the sensitive pressure 
point such as elbow and heel in supine position.2,3,4
Several precautions of some complications 
perioperative for liposuction also should be 
addressed. According to Grazer and De Jong have 
identified a total number of 130 deaths in almost 
500,000 surgical procedure, of which the most 
important causes were thromboembolism (23.1%), 
abdomen or viscera perforation (14.6%), anes-
thesia/sedation/medication (10%), fat embolism 
(8.5%) and others (43.9%).3 One of the most feared 
complications is deep vein thrombosis and pulmo-
nary embolism, which the incidence has been 
reported <1% in liposuction, but marked increase 
when combined with other surgery (abdomino-
plasty/sleeve gastrectomy). The use of preven-
tive measures (stocking, pneumatic intermittent 
compression, etc), together with early mobilization, 
and anticoagulation (if indicated) are sufficient to 
prevent the risk of DVT.3 In this patient, there were 
no clinical signs of DVT reported during admission. 
Fat embolism syndrome (FES) occurs in 5-10% of 
the cases, but is usually minor, self-limiting disease, 
and resolved within a week. However, the clinician 
should not underestimate its importance as it can 
share the same features as other fatal complication 
such as pulmonary embolism and sepsis, especially 
for the fulminant FES. The clinician should be 
aware if there are three classic symptoms of FES 
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as follow: respiratory distress, cerebral dysfunc-
tion, and petechial rash, usually appear within 
24-72 hours after the procedure.3 There were no 
signs of FES reported from this patient.
Another most common postoperative complica-
tion is postoperative nausea and vomiting (PONV) 
with the incidence range >35% has reported. 
Antiemetic medication with ondansetron 4-8 mg 
IV or SL, a serotonin antagonist, is probably the 
most effective and safe postoperative anti-emetic 
(compared with droperidol 0.625-1.25mg IV, the 
most common used anti-emetic prior, but recently 
considered unsafe due to its potential cardiac 
complications). This patient has experienced one 
episode of nausea and vomiting which was well 
controlled by ondansetron 8mg IV. For the postop-
erative analgesia, the requirement may be minimal, 
as the numeric pain scale postoperatively ranges 
between 2-4.8 the non-steroid anti-inflammatory 
drugs (NSAIDs) may also be prescribed for pain 
relief in combination with mild to moderate opiate 
analgesics such as tramadol or codein.1,5,8
CONCLUSION
Liposuction is one of the most popular treatment 
modalities in aesthetic surgery due to increased 
awareness of the advances in the field of plastic 
surgery and anesthesia. Its low complication rate 
accentuated this procedure popularity, hence 
should be considered a safe surgical procedure. By 
following the protocols carefully, liposuction can be 
a safe procedure that results in significant patient 
outcome and satisfaction. 
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